James River Group Holdings Ltd
Change company Symbol lookup
Select an option...
JRVR James River Group Holdings Ltd
DIDIY DiDi Global Inc
SHOP Shopify Inc
NTR Nutrien Ltd
APGN Apexigen Inc
NSRGY Nestle SA
WE WeWork Inc
NOK Nokia Oyj
HLNE Hamilton Lane Inc
SAL Salisbury Bancorp Inc
Go

Financials : Insurance | Small Cap Value
Based in Bermuda
Company profile

James River Group Holdings, Ltd. owns and operates a group of specialty insurance and reinsurance companies. It operates in four segments: Excess and Surplus Lines, Specialty Admitted Insurance, Casualty Reinsurance and Corporate and Other. Excess and Surplus Lines segment offers commercial excess and surplus lines liability and property insurance. Specialty Admitted Insurance segment approaches the insurance market in two ways: as a risk bearing underwriter, and as a fronting company. Its risk bearing underwriting is focused on niche classes within the insurance markets, such as workers’ compensation coverage for residential contractors, light manufacturing operations, transportation workers and healthcare worker. Casualty Reinsurance segment primarily provides proportional and working layer casualty reinsurance to third parties (primarily through reinsurance intermediaries). Corporate and Other segment consists of the management and treasury activities of its holding companies.

Price
Delayed
$25.50
Day's Change
-0.55 (-2.11%)
Bid
--
Ask
--
B/A Size
--
Day's High
26.02
Day's Low
25.49
Volume
(Light)

Today's volume of 44,324 shares is on pace to be much lighter than JRVR's 10-day average volume of 168,410 shares.

44,324

DEADLINE ALERT for APYX, VRCA, APPS, and TDOC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

11:45 am ET June 30, 2022 (Globe Newswire) Print

EQNX::TICKER_START (NASDAQ:APYX),(NasdaqGM:VRCA),(NASDAQ:APPS),(NYSE:TDOC), EQNX::TICKER_END The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com.

Apyx Medical Corporation (NASDAQ: APYX)

Class Period: May 12, 2021 - March 11, 2022

Lead Plaintiff Deadline: August 5, 2022

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that a significant number of Apyx's Advanced Energy products were used for off-label indications; (2) that such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) that, as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) that, as a result of the foregoing, the Company's financial results would be adversely impacted; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA)

Class Period: May 28, 2021 - May 24, 2022

Lead Plaintiff Deadline: August 5, 2022

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that there were manufacturing deficiencies at the facility where Verrica's contract manufacturer produced bulk solution for VP-102; (2) that these deficiencies were not remediated when Verrica resubmitted its NDA for VP-12 for molluscum; (3) that the foregoing presented significant risks to Verrica obtaining regulatory approval of VP-102 for molluscum; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Digital Turbine, Inc. (NASDAQ: APPS)

Class Period: August 9, 2021 - May 17, 2022

Lead Plaintiff Deadline: August 5, 2022

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company's recent acquisitions, AdColony and Fyber, act as agents in certain of their respective product lines; (2) that, as a result, revenues for those product lines must be reported net of license fees and revenue share, rather than on a gross basis; (3) that the Company's internal control over financial reporting as to revenue recognition was deficient; and (4) that, as a result of the foregoing, the Company's net revenues was overstated throughout fiscal 2022; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Teladoc Health, Inc. (NYSE: TDOC)

Class Period: October 28, 2021 - April 27, 2022

Lead Plaintiff Deadline: August 5, 2022

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) increased competition, among other factors, was negatively impacting Teladoc's BetterHelp and chronic care businesses; (2) accordingly, the growth of those businesses was less sustainable than Defendants had led investors to believe; (3) as a result, Teladoc's revenue and adjusted EBITDA projections for FY 2022 were unrealistic; (4) as a result of all the foregoing, Teladoc would be forced to recognize a significant non-cash goodwill impairment charge; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles

Frank R. Cruz, 310-914-5007

fcruz@frankcruzlaw.com

www.frankcruzlaw.com

https://ml.globenewswire.com/media/778ea178-25d1-48a3-9141-a162814899d4/small/close-up-logo-hd-blue-jpg.jpg

https://ml.globenewswire.com/media/778ea178-25d1-48a3-9141-a162814899d4/small/close-up-logo-hd-blue-jpg.jpg

comtex tracking

COMTEX_409484055/2010/2022-06-30T11:45:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.